共 58 条
[1]
Ball P(2002)Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence J Antimicrob Chemother 49 31-40
[2]
Baquero F(2009)Pathogenesis, treatment, and prevention of pneumococcal pneumonia Lancet 374 1543-56
[3]
Cars O(2001)A multicenter study of the antimicrobial susceptibility of Microb Drug Resist 7 33-8
[4]
van der Poll T(2004), and J Antimicrob Chemother 53 1018-32
[5]
Opal SM(2006) isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal Rev Port Pneumol 12 9-30
[6]
Melo-Cristino J(1995)Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001–2002: the BSAC Bacteraemia Resistance Surveillance Programme Microb Drug Resist 1 59-69
[7]
Fernandes ML(2005)The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004 Clin Microbiol Infect 11 985-91
[8]
Serrano N(2006)Antibiotic susceptibility of Lancet Infect Dis 6 405-10
[9]
Reynolds R(2010) isolates in Portugal. A multicenter study between 1989 and 1993 Diagn Microbiol Infect Dis 67 78-86
[10]
Potz N(2007)Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003 J Infect 55 111-8